Publications by authors named "B Vandercam"

Claim this Profile
D
Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study.
Julien De Greef, Jean Cyr Yombi, Anne Vincent, Bernard Vandercam, Philippe de Timary

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional study.
Julien De Greef, Khoi Nguyen Nguyen, Matthias Van Hul, Anthony Puel, Jean Cyr Yombi, Bernard Vandercam

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Johan Maertens, Tom Lodewyck, J Peter Donnelly, Sylvain Chantepie, Christine Robin, Bernard Vandercam

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic model.
Gabriel Stillemans, Leila Belkhir, Bernard Vandercam, Anne Vincent, Vincent Haufroid

Eur J Clin Pharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of Reduced Doses and Short-Cycle Therapy for Darunavir/Cobicistat in Patients with HIV Using Population Pharmacokinetic Modeling and Simulations.
Gabriel Stillemans, Leila Belkhir, Bernard Vandercam, Anne Vincent, Vincent Haufroid

Clin Pharmacokinet· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis